Skip to content

Insider · CIK 0001432063

Rui Avelar

officer

Files at EOLS (Evolus, Inc.). First filing Feb 23, 2024, latest Mar 20, 2026.

In brief

Rui Avelar files SEC Form 4 as officer at EOLS (Evolus, Inc.). Since Feb 23, 2024, Rui Avelar has reported 0 open-market buys worth $0 and 8 open-market sells worth $1.0M, the latest filed on Mar 20, 2026.

A track record needs three past buys with six months of prices behind them; Rui Avelar has 0, so none is measured yet.

The newest scored trade: sold $15k of EOLS on Mar 20, 2026, filed Mar 20, 2026, scored 3 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $178k.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 8
$0 bought, $1.0M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

EOLS: Evolus, Inc.

EOLSOct 9, 2026 · close 7.73

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
3Weak
EOLSsell 210b5-1
Evolus, Inc.
$15k
3,119 shares
-1%+12% from low-65% from high
0Weak
EOLSsell 210b5-1
Evolus, Inc.
$147k
29,996 shares
-7%+19% from low-64% from high
3Weak
EOLSsell 210b5-1
Evolus, Inc.
$16k
2,261 shares
-1%+25% from low-52% from high
16Weak
EOLSsell 310b5-1
Evolus, Inc.
$33k
3,385 shares
-1%+7% from low-43% from high
25Weak
EOLSsell 510b5-1
Evolus, Inc.
$370k
27,904 shares
-7%-
10Weak
EOLSsell 310b5-1
Evolus, Inc.
$24k
2,252 shares
-1%-
46Moderate
EOLSsell 3
Evolus, Inc.
$384k
27,603 shares
-7%+96% from low-6% from high
10Weak
EOLSsell 310b5-1
Evolus, Inc.
$24k
1,821 shares
-0%+84% from low-4% from high

Transactions

Every row this insider has filed, 20 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 20, 2026EOLS
Evolus, Inc.
SOpen-market sale
Common Stock10b5-1
-3,119$4.75$15k427,423Mar 20, 2026
Mar 16, 2026EOLS
Evolus, Inc.
MOption exercise
Common Stock10b5-1
+8,804$0.00$0460,538Mar 18, 2026
Mar 17, 2026EOLS
Evolus, Inc.
SOpen-market sale
Common Stock10b5-1
-29,996$4.89$147k430,542Mar 18, 2026
Mar 16, 2026EOLS
Evolus, Inc.
MOption exercise
Performance Restricted Stock Unitsderivative10b5-1
-8,804$0.00$08,802Mar 18, 2026
Feb 17, 2026EOLS
Evolus, Inc.
AGrant or award
Common Stock
+94,913$0.00$0451,734Feb 19, 2026
Feb 17, 2026EOLS
Evolus, Inc.
AGrant or award
Performance Restricted Stock Unitsderivative
+94,913$0.00$094,913Feb 19, 2026
Feb 17, 2026EOLS
Evolus, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+138,649$0.00$0138,649Feb 19, 2026
Dec 22, 2025EOLS
Evolus, Inc.
SOpen-market sale
Common Stock10b5-1
-2,261$7.15$16k356,821Dec 29, 2025
May 12, 2025EOLS
Evolus, Inc.
SOpen-market sale
Common Stock10b5-1
-3,385$9.87$33k359,082May 14, 2025
Mar 18, 2025EOLS
Evolus, Inc.
SOpen-market sale
Common Stock10b5-1
-27,904$13.26$370k362,467Mar 20, 2025
Mar 7, 2025EOLS
Evolus, Inc.
AGrant or award
Common Stock
+23,776$0.00$0390,371Mar 11, 2025
Mar 7, 2025EOLS
Evolus, Inc.
AGrant or award
Performance Restricted Stock Unitsderivative
+23,776$0.00$023,776Mar 11, 2025
Mar 7, 2025EOLS
Evolus, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+33,875$0.00$033,875Mar 11, 2025
Dec 23, 2024EOLS
Evolus, Inc.
SOpen-market sale
Common Stock10b5-1
-2,252$10.85$24k366,595Dec 26, 2024
Mar 19, 2024EOLS
Evolus, Inc.
SOpen-market sale
Common Stock
-27,603$13.92$384k372,288Mar 21, 2024
Feb 21, 2024EOLS
Evolus, Inc.
AGrant or award
Common Stock10b5-1
+13,115$0.00$0401,712Feb 23, 2024
Feb 22, 2024EOLS
Evolus, Inc.
SOpen-market sale
Common Stock10b5-1
-1,821$13.08$24k399,891Feb 23, 2024
Feb 7, 2024EOLS
Evolus, Inc.
AGrant or award
Common Stock
+35,211$0.00$0388,597Feb 9, 2024
Feb 7, 2024EOLS
Evolus, Inc.
AGrant or award
Performance Restricted Stock Unitsderivative
+17,606$0.00$017,606Feb 9, 2024
Feb 7, 2024EOLS
Evolus, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+47,337$0.00$047,337Feb 9, 2024

Questions about Rui Avelar

Answered from the filings on this page, as of the latest one.

Is Rui Avelar buying or selling?

In the last 12 months Rui Avelar reported 0 open-market buys worth $0 and 3 open-market sells worth $178k on SEC Form 4; the latest was sold $15k of EOLS on Mar 20, 2026. Grants, option exercises and tax withholding are not counted.

How did Rui Avelar's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Rui Avelar has 0.

Where does Rui Avelar file Form 4?

Rui Avelar has filed Form 4 at EOLS (Evolus, Inc.) as See Remarks. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Rui Avelar: insider trades and track record | InsiderTell